Rifampicin and moxifloxacin for tuberculous meningitis – Authors' reply
Authors:
- Rovina RuslamiRRRovina Ruslami
- A Rizal GaniemAGA Rizal Ganiem
- Rob E AarnoutseRARob E Aarnoutse
- Reinout van CrevelRCReinout van Crevel
- 1 July 2013
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 13 (7) , 570
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous MeningitisClinical Infectious Diseases, 2009
- Experimental Models of Tuberculosis: Can We Trust the Mouse?American Journal of Respiratory and Critical Care Medicine, 2009
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006